Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001416083-14-000007
Filing Date
2014-02-10
Accepted
2014-02-10 13:27:29
Documents
11
Period of Report
2013-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q catalent-20131231x10q.htm 10-Q 1894055
2 EXHIBIT catalent-20131231xex311.htm EX-31.1 8595
3 EXHIBIT catalent-20131231xex312.htm EX-31.2 8722
4 EXHIBIT catalent-20131231xex321.htm EX-32.1 5070
5 EXHIBIT catalent-20131231xex322.htm EX-32.2 4802
  Complete submission text file 0001416083-14-000007.txt   15374335

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ck0001416083-20131231.xml EX-101.INS 3296981
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ck0001416083-20131231.xsd EX-101.SCH 58684
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ck0001416083-20131231_cal.xml EX-101.CAL 109628
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ck0001416083-20131231_def.xml EX-101.DEF 189041
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ck0001416083-20131231_lab.xml EX-101.LAB 582162
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ck0001416083-20131231_pre.xml EX-101.PRE 371249
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent Pharma Solutions, Inc. (Filer) CIK: 0001416083 (see all company filings)

EIN.: 133523163 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 333-147871 | Film No.: 14587503
SIC: 2834 Pharmaceutical Preparations